Form 8-K - Current report:
SEC Accession No. 0001493152-25-011441
Filing Date
2025-07-28
Accepted
2025-07-28 09:20:23
Documents
15
Period of Report
2025-07-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 40791
2 EX-99.1 ex99-1.htm EX-99.1 22876
3 EX-99.2 ex99-2.htm EX-99.2 33297
4 GRAPHIC ex99-1_001.jpg GRAPHIC 10025
  Complete submission text file 0001493152-25-011441.txt   286515

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aim-20250728.xsd EX-101.SCH 3014
6 XBRL LABEL FILE aim-20250728_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE aim-20250728_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3564
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 251153237
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)